Oral thin films market seen reaching $9.82 billion by 2030

The Business Research Company says the oral thin films market grew from $4.99 billion in 2025 to $5.72 billion in 2026 and is projected to reach $9.82 billion by 2030. The report points to faster drug delivery, patient-friendly dosage forms and expanding OTC use as key drivers, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - Oral thin films are gaining traction as a non-invasive drug delivery option that can improve convenience, self-administration and rapid absorption. - The market outlook signals continued demand for therapies that work quickly and fit preferences for easier-to-use treatments. - The category is also relevant for pediatric and geriatric care, where simpler dosage forms can improve compliance.

What happened: - The Business Research Company published an oral thin films market report with a 2026 outlook and a forecast 14.4% CAGR through 2030. - The market grew from $4.99 billion in 2025 to $5.72 billion in 2026, a 14.6% CAGR in the historical period. - The report projects the market will reach $9.82 billion by 2030. - A free sample of the report is available here. - The full report is available here.

The details: - Oral thin films are ultra-thin polymer films placed in the mouth to deliver therapeutic agents through the oral cavity or gastrointestinal tract. - The films are designed to absorb into the bloodstream after administration. - The report ties growth to rising demand for thin film drug delivery systems, broader treatment use in psychiatric and neurological disorders, and wider acceptance of OTC formats. - Fast dissolution and no need for water make oral thin films a practical alternative to tablets and capsules. - The report also cites increased investment in innovative polymer formulations and improved film manufacturing techniques. - Regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is projected to grow the fastest during the forecast period.

Between the lines: - The forecast suggests oral thin films are moving from niche delivery technology toward a broader commercial platform for consumer-friendly and specialty therapies. - The emphasis on personalized medicine, OTC oral therapeutics and bioavailability points to a market shaped by convenience as much as clinical need. - The report’s growth assumptions also reflect rising demand linked to chronic disease treatment needs, including cancer and cardiovascular conditions.

What's next: - The market is expected to benefit from more fast-acting drug delivery films and broader use of polymer-based technologies. - Product development will likely focus on improving bioavailability and expanding patient-friendly dosage options. - Asia-Pacific could become a bigger growth engine as healthcare access and awareness improve. - The Business Research Company has added market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards and updated graphics to its 2026 reports.

The bottom line: - Oral thin films are on a strong growth path, with the market projected to nearly double from 2026 to 2030 as demand shifts toward easier, faster and more patient-friendly drug delivery.